0CAN049510, Submits Drug Testing Lab Performance Rept
| ML20087H488 | |
| Person / Time | |
|---|---|
| Site: | Arkansas Nuclear  |
| Issue date: | 04/26/1995 |
| From: | Mims D ENTERGY OPERATIONS, INC. |
| To: | NRC OFFICE OF INFORMATION RESOURCES MANAGEMENT (IRM) |
| References | |
| 0CAN049510, CAN49510, NUDOCS 9505030163 | |
| Download: ML20087H488 (3) | |
Text
,
cnt2rgy opirations, Inc.
-:'ENTERGY
" % # nam Tet 501858&OO P
April 26,1995 OCAN049510 U. S. Nuclear Regulatoy Commission Document Control Desk Mail Sta;;on Pl-137 Washington, DC 20555
Subject:
Arkansas Nuclear One - Units I and 2 Docket Nos. 50-313 and 50-368 License Nos. DPR-51 and NPF-6 Dmg Testing Laboratory Performance Report Gentlemen:
As part of the routine blind performance drug testing program, a spiked sample certified to be
" positive" for amphetamine was screened " positive" for the presence of amphetamine by Arkansas Nuclear One (ANO) Fitness For Duty personnel and submitted to the SmithKline Beecham Clinical Laboratories on December 30,1994. The result of this test was released to ANO on January 2,1995, as " negative." Upon receipt of this test report, ANO sent a second aliquot of the same sample to SmithKline Beecham on January 4,1995. On January 11,1995, the laboratory reported that the second aliquot had been screened " positive" and confirmed
" positive" for amphetamine. Due to the discrepancy between test results from the same sample, an investigation was requested of SmithKline Beecham on January 27,1995. ANO j
sent letters to SmithKline Beecham on February 14,1995, and March 23,1995, requesting the investigation results. ANO received the report of the investigation dated March 28,1995, on March 31,1995.
This report states that the original aliquot was screened " positive" for amphetamine; however, due to an enor by a technician, it was not submitted for gas chromatography / mass spectrometry (GC/MS) and was erroneously reported as " negative."
In accordance with paragraph 2.8(e)(4) of Appendix "A" to 10CFR26, enclosed is the investigation report provided to ANO by SmithKline Beecham concerning the unsatisfactory performance test result.
i i
9505oso16s 950426 f
p PDR ADOCK 0500 3
P lig(
J.,.[
D S.NRC E
' ' April 26,1995 -.
l OCAN049510 Page 2 The enclosure to the SmithKline Beecham letter is not being transmitted because it contains
. confidential information regarding other positive samples that does not assist in understanding
. the condition.' A copy of the enclosure is available for review at ANO.
Very truly yours, f
h C.'73f Dwight C. Mims Director, Licensing DCM/tfs Enclosure cc:
Mr. Leonard J. Callan Regional Administrator U. S. Nuclear Regulatory Commission RegionIV 611 Ryan Plaza Drive, Suite 400 Arlington, TX 76011-8064 NRC Senior Resident Inspector Arkansas Nuclear One 1448 S. R. 333 '
Russellville, AR 72801 Mr. George Kalman NRR Project Manager Region IV/ANO-1 & 2 U. S. Nuclear Regulatory Commission NRR Mail Stop 13-H-3 One White Flint North 11555 Rockville Pike Rockville, MD 20852 Dr. Michael Schaffer Director of Toxicology.
SmithKline Beecham Clinical Laboratories l
801 E. Dixie Ave.
.Leesburg, FL 34748 L
. ~..
g
...t SmithKima Beech m ClinicalLaboratories Michael 1. Schaffer, Ph.D.
March 28, 1995 Jerry F. Hodges, M.D., MRO Arkansas Nuclear One Entergy Operations, Inc.
1448 SR 333 Russellville, AR 72801 RE: LB2147 273815F
Dear Dr. Hodges:
The above mentioned specimen was submitted for testing on 30 December 1994.
It was received into the laboratory on 31 December 1994.
The sample was aliquotted for testing on the Abbott TDX analyzer. It appears on the TDX printout as specimen number 9, with the result HI >=T. The result for that test was a positive result.
The technician errored and entered the result as a negative instead of the positive.
The result was released as a negative on 2 January 1995.
Receipt of your letter and the submission of this sample for GC/MS confirmation revealed a
positive amphetamine and methamphetamine.
This specimen result was released under the accession number 277149F.
The concentrations of amphetamine and methamphetamine determined were 1169 and 1196 ng/ml respectively.
Copies of the first TDX printout, and a copy of the MFR are enclosed.
The individuals involved have been counseled in this matter.
We sincerely regret this occurrence, and have informed all staff involved in the Abbott TDX methodology to pay closer attention to detail in this area, as this process is a manual one.
We respectively regret the negative entry on the first result.
I hope that this information resolves this to your satisfaction.
Respectively.u
.itted,
)
Mich 1 I.
Schaffer Ph.D.,
D.A.B.F.T.
Dire or Of Toxicol y
CX: R. T. Chamberlain, J.D.,Ph.D.
h Kathe Russell, B.S.
Enclosure i
801 E. Dixie Avenue, Leesburg, FL 34748
- 800-342-9520 j